TEVA logo

TEVA Shareholders equity

annual shareholders equity:

$5.37B-$2.13B(-28.42%)
December 31, 2024

Summary

  • As of today (May 30, 2025), TEVA annual stockholders equity is $5.37 billion, with the most recent change of -$2.13 billion (-28.42%) on December 31, 2024.
  • During the last 3 years, TEVA annual shareholders equity has fallen by -$4.91 billion (-47.72%).
  • TEVA annual shareholders equity is now -83.88% below its all-time high of $33.34 billion, reached on December 31, 2016.

Performance

TEVA Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAbalance sheet metrics

quarterly shareholders equity:

$6.26B+$889.00M(+16.55%)
March 31, 2025

Summary

  • As of today (May 30, 2025), TEVA quarterly stockholders equity is $6.26 billion, with the most recent change of +$889.00 million (+16.55%) on March 31, 2025.
  • Over the past year, TEVA quarterly shareholders equity has dropped by -$1.02 billion (-13.96%).
  • TEVA quarterly shareholders equity is now -82.17% below its all-time high of $35.13 billion, reached on September 30, 2016.

Performance

TEVA quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

TEVA Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-28.4%-14.0%
3 y3 years-47.7%-33.0%
5 y5 years-61.5%-53.7%

TEVA Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-47.7%at low-33.0%+16.6%
5 y5-year-61.5%at low-54.8%+16.6%
alltimeall time-83.9%>+9999.0%-82.2%>+9999.0%

TEVA Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$6.26B(+16.5%)
Dec 2024
$5.37B(-28.4%)
$5.37B(-11.4%)
Sep 2024
-
$6.07B(-4.6%)
Jun 2024
-
$6.36B(-12.6%)
Mar 2024
-
$7.28B(-3.0%)
Dec 2023
$7.51B(-3.8%)
$7.51B(+8.3%)
Sep 2023
-
$6.93B(-1.7%)
Jun 2023
-
$7.05B(-10.3%)
Mar 2023
-
$7.86B(+0.7%)
Dec 2022
$7.80B(-24.1%)
$7.80B(-11.0%)
Sep 2022
-
$8.77B(-3.0%)
Jun 2022
-
$9.04B(-3.3%)
Mar 2022
-
$9.34B(-9.1%)
Dec 2021
$10.28B(+2.5%)
$10.28B(-1.8%)
Sep 2021
-
$10.47B(+1.4%)
Jun 2021
-
$10.32B(+3.2%)
Mar 2021
-
$10.00B(-0.3%)
Dec 2020
$10.03B(-28.2%)
$10.03B(+4.5%)
Sep 2020
-
$9.59B(-30.7%)
Jun 2020
-
$13.85B(+2.4%)
Mar 2020
-
$13.53B(-3.2%)
Dec 2019
$13.97B(-5.0%)
$13.97B(+1.3%)
Sep 2019
-
$13.79B(-2.4%)
Jun 2019
-
$14.12B(-4.1%)
Mar 2019
-
$14.73B(+0.2%)
Dec 2018
$14.71B(-15.3%)
$14.71B(-17.1%)
Sep 2018
-
$17.73B(-1.2%)
Jun 2018
-
$17.94B(-3.7%)
Mar 2018
-
$18.62B(+7.3%)
Dec 2017
$17.36B(-47.9%)
$17.36B(-39.5%)
Sep 2017
-
$28.67B(+2.4%)
Jun 2017
-
$27.99B(-17.7%)
Mar 2017
-
$34.02B(+2.1%)
Dec 2016
$33.34B(+12.0%)
$33.34B(-5.1%)
Sep 2016
-
$35.13B(+16.5%)
Jun 2016
-
$30.15B(-0.9%)
Mar 2016
-
$30.43B(+2.2%)
Dec 2015
$29.77B(+27.7%)
$29.77B(+30.9%)
Sep 2015
-
$22.74B(-1.3%)
Jun 2015
-
$23.04B(+1.8%)
Mar 2015
-
$22.64B(-2.9%)
Dec 2014
$23.31B(+3.3%)
$23.31B(-1.4%)
Sep 2014
-
$23.63B(+0.4%)
Jun 2014
-
$23.54B(+2.5%)
Mar 2014
-
$22.97B(+1.8%)
Dec 2013
$22.57B(-0.9%)
$22.57B(+1.2%)
Sep 2013
-
$22.31B(+3.7%)
Jun 2013
-
$21.52B(-5.3%)
Mar 2013
-
$22.71B(-0.2%)
Dec 2012
$22.77B(+2.6%)
$22.77B(-0.7%)
Sep 2012
-
$22.93B(+0.8%)
Jun 2012
-
$22.75B(-1.3%)
Mar 2012
-
$23.05B(+3.9%)
Dec 2011
$22.20B(+1.1%)
$22.20B(-2.9%)
Sep 2011
-
$22.86B(-3.5%)
Jun 2011
-
$23.68B(+2.7%)
Mar 2011
-
$23.07B(+5.1%)
Dec 2010
$21.95B
$21.95B(+1.3%)
Sep 2010
-
$21.67B(+12.1%)
Jun 2010
-
$19.33B(-1.6%)
DateAnnualQuarterly
Mar 2010
-
$19.65B(+2.2%)
Dec 2009
$19.22B(+17.9%)
$19.22B(-0.2%)
Sep 2009
-
$19.26B(+8.1%)
Jun 2009
-
$17.82B(+10.4%)
Mar 2009
-
$16.14B(-1.0%)
Dec 2008
$16.30B(+18.8%)
$16.30B(+9.8%)
Sep 2008
-
$14.84B(-1.5%)
Jun 2008
-
$15.07B(+4.7%)
Mar 2008
-
$14.40B(+4.9%)
Dec 2007
$13.72B(+23.2%)
$13.72B(+6.2%)
Sep 2007
-
$12.92B(+7.1%)
Jun 2007
-
$12.06B(+5.9%)
Mar 2007
-
$11.39B(+2.2%)
Dec 2006
$11.14B(+84.4%)
$11.14B(+5.3%)
Sep 2006
-
$10.58B(+6.8%)
Jun 2006
-
$9.90B(+7.4%)
Mar 2006
-
$9.22B(+52.6%)
Dec 2005
$6.04B(+12.1%)
$6.04B(+8.5%)
Sep 2005
-
$5.57B(+4.8%)
Jun 2005
-
$5.31B(+0.2%)
Mar 2005
-
$5.30B(-1.7%)
Dec 2004
$5.39B(+63.8%)
$5.39B(+5.7%)
Sep 2004
-
$5.10B(+13.1%)
Jun 2004
-
$4.51B(+4.9%)
Mar 2004
-
$4.29B(+30.6%)
Dec 2003
$3.29B(+79.8%)
$3.29B(+37.8%)
Sep 2003
-
$2.39B(+8.3%)
Jun 2003
-
$2.21B(+11.3%)
Mar 2003
-
$1.98B(+8.3%)
Dec 2002
$1.83B(+32.5%)
$1.83B(+10.9%)
Sep 2002
-
$1.65B(+4.1%)
Jun 2002
-
$1.58B(+9.4%)
Mar 2002
-
$1.45B(+4.8%)
Dec 2001
$1.38B(+19.9%)
$1.38B(+4.5%)
Sep 2001
-
$1.32B(+5.6%)
Jun 2001
-
$1.25B(+6.4%)
Mar 2001
-
$1.17B(+2.0%)
Dec 2000
$1.15B(+54.1%)
$1.15B(+5.3%)
Sep 2000
-
$1.09B(+2.4%)
Jun 2000
-
$1.07B(+38.5%)
Mar 2000
-
$771.04M(+3.2%)
Dec 1999
$747.23M(+13.4%)
$747.23M(+5.3%)
Sep 1999
-
$709.30M(+1.8%)
Jun 1999
-
$696.50M(+3.5%)
Mar 1999
-
$673.20M(+2.2%)
Dec 1998
$658.80M(+7.6%)
$658.80M(-0.5%)
Sep 1998
-
$662.20M(+3.3%)
Jun 1998
-
$641.00M(+1.7%)
Mar 1998
-
$630.30M(+3.0%)
Dec 1997
$612.00M(+14.6%)
$612.00M(+14.6%)
Dec 1996
$534.20M(+10.7%)
$534.20M(+10.7%)
Dec 1995
$482.50M(+41.1%)
$482.50M(+41.1%)
Dec 1994
$342.00M(+27.9%)
$342.00M(+27.9%)
Dec 1993
$267.50M(+20.3%)
$267.50M(+20.3%)
Dec 1992
$222.30M(+21.9%)
$222.30M(+21.9%)
Dec 1991
$182.40M(+34.5%)
$182.40M(+34.5%)
Dec 1990
$135.60M(+13.6%)
$135.60M(+13.6%)
Dec 1989
$119.40M(+20.5%)
$119.40M(+20.5%)
Dec 1988
$99.10M(+71.5%)
$99.10M(+71.5%)
Mar 1987
$57.80M(+15.8%)
$57.80M(+15.8%)
Mar 1986
$49.90M
$49.90M

FAQ

  • What is Teva Pharmaceutical Industries Limited annual stockholders equity?
  • What is the all time high annual shareholders equity for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual shareholders equity year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly shareholders equity year-on-year change?

What is Teva Pharmaceutical Industries Limited annual stockholders equity?

The current annual shareholders equity of TEVA is $5.37B

What is the all time high annual shareholders equity for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual stockholders equity is $33.34B

What is Teva Pharmaceutical Industries Limited annual shareholders equity year-on-year change?

Over the past year, TEVA annual stockholders equity has changed by -$2.13B (-28.42%)

What is Teva Pharmaceutical Industries Limited quarterly stockholders equity?

The current quarterly shareholders equity of TEVA is $6.26B

What is the all time high quarterly shareholders equity for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly stockholders equity is $35.13B

What is Teva Pharmaceutical Industries Limited quarterly shareholders equity year-on-year change?

Over the past year, TEVA quarterly stockholders equity has changed by -$1.02B (-13.96%)
On this page